Bacillus spp. Inhibit Edwardsiella tarda Quorum-Sensing and Fish Infection

The disruption of pathogen communication or quorum-sensing (QS) via quorum-quenching (QQ) molecules has been proposed as a promising strategy to fight bacterial infections. Bacillus spp. have recognizable biotechnology applications, namely as probiotic health-promoting agents or as a source of natural antimicrobial molecules, including QQ molecules. This study characterized the QQ potential of 200 Bacillus spp., isolated from the gut of different aquaculture fish species, to suppress fish pathogens QS. Approximately 12% of the tested Bacillus spp. fish isolates (FI). were able to interfere with synthetic QS molecules. Ten isolates were further selected as producers of extracellular QQ-molecules and their QQ capacity was evaluated against the QS of important aquaculture bacterial pathogens, namely Aeromonas spp., Vibrio spp., Photobacterium damselae, Edwardsiela tarda, and Shigella sonnei. The results revealed that A. veronii and E. tarda produce QS molecules that are detectable by the Chr. violaceum biosensor, and which were degraded when exposed to the extracellular extracts of three FI isolates. Moreover, the same isolates, identified as B. subtilis, B. vezelensis, and B. pumilus, significantly reduced the pathogenicity of E. tarda in zebrafish larvae, increasing its survival by 50%. Taken together, these results identified three Bacillus spp. capable of extracellularly quenching aquaculture pathogen communication, and thus become a promising source of bioactive molecules for use in the biocontrol of aquaculture bacterial diseases.


Introduction
Despite experiencing continuous growth, the development of aquaculture remains highly vulnerable to the occurrence of infectious bacterial diseases. Furunculosis, edwardsielosis, vibriosis, and photobacteriosis are among the most prevalent diseases, with serious effects on marine fish species [1]. Although antibiotics are an important tool for disease treatment, their damaging effects on the environment and public health have led to increased restrictions on their use in aquaculture [2]. An alternative to antibiotics relies on attenuating pathogen virulence, a process called anti-virulence therapy [3].
Virulence factors (e.g., motility, extracellular polysaccharides, biofilms, lytic enzymes, or secretion systems) enable bacterial pathogens to colonize and damage their host. Their species, and tested their ability to degrade the AHLs signals produced by important fish pathogenic strains. After validation of fish isolates (FIs) with QQ capacity, their potential protective effects were determined in an in vivo model (zebrafish larvae) when challenged with E. tarda.
B. cereus strains showed QQ and protective activities against Y. ruckeri in rainbow trout [34].
This study screened the QQ capacity of the extracellular components of a collection of Bacillus spp., which were previously isolated from the gut of different marine fish species, and tested their ability to degrade the AHLs signals produced by important fish pathogenic strains. After validation of fish isolates (FIs) with QQ capacity, their potential protective effects were determined in an in vivo model (zebrafish larvae) when challenged with E. tarda.

Figure 1.
Violacein pigment production by Chr. violaceum biosensors when exposed to sporeforming fish isolates. (A) Inhibition of biosensor's violacein pigment production by FI isolates (FI numbers on top). (B) Biosensor's violacein pigment inhibition by the cell-free supernatant of sporeforming fish isolates (FI numbers on top). All photos were taken with a Sony IMX240 camera and are at the same scale.
When testing their cell-free supernatants (to establish the intra-or extracellular localization of the QQ compounds), it became clear that FI did not produce extracellular compounds capable of interfering with all AHLs of the wild-type biosensor ( Figure 1B). In contrast, the inhibition of violacein pigment production was observed in the CV026 biosensor supplemented with 5 µ M of 3-Oxo-C6-HSL, and was particularly evident in FI314, FI330, and FI464, which showed stronger activity when compared to the other isolates ( Figure 1B). These results indicate that FI isolates produce extracellular compounds with Figure 1. Violacein pigment production by Chr. violaceum biosensors when exposed to sporeforming fish isolates. (A) Inhibition of biosensor's violacein pigment production by FI isolates (FI numbers on top). (B) Biosensor's violacein pigment inhibition by the cell-free supernatant of sporeforming fish isolates (FI numbers on top). All photos were taken with a Sony IMX240 camera and are at the same scale.
When testing their cell-free supernatants (to establish the intra-or extracellular localization of the QQ compounds), it became clear that FI did not produce extracellular compounds capable of interfering with all AHLs of the wild-type biosensor ( Figure 1B). In contrast, the inhibition of violacein pigment production was observed in the CV026 biosensor supplemented with 5 µM of 3-Oxo-C6-HSL, and was particularly evident in FI314, FI330, and FI464, which showed stronger activity when compared to the other isolates ( Figure 1B). These results indicate that FI isolates produce extracellular compounds with QQ capacity against at least 3-Oxo-C6-HSL QS molecules. The laboratory strain B. subtilis 168 could not inhibit pigment production of the biosensors in both bioassays.

Isolates QQ Activity Is Mediated through AHLs Enzymatic Inactivation
To evaluate the catalyst nature of the QQ activity observed in the previous experiment, the extracellular compounds of all positive strains (FI314, FI330, FI333, FI335, FI346, FI383, FI423, FI436, FI442, and FI464) were mixed for 24 h with 30 µM of synthetic 3-Oxo-C6-HSL, before a bioassay with CV026 biosensor. In this, the reduction in the violacein halo when submitted to the H24 reaction mixture, when compared to a fresh reaction mixture (H0), indicates lactone degradation by the extracellular compounds present on the FI supernatants, and thus an enzymatic reaction. The FI extracellular compounds mixed with the 3-Oxo-C6-HSL led to a reduction in pigment production by the biosensor in all combinations, with strains FI314, FI330, FI346, and FI464 showing the highest activity ( Figure 2A). A reduction in the pigment production was also noticed when using the fresh (0H) reactions of strains FI314, FI330, and FI464, which might indicate the presence of signal blockers (Figure 2A) on their supernatant. QQ capacity against at least 3-Oxo-C6-HSL QS molecules. The laboratory strain B. subtilis 168 could not inhibit pigment production of the biosensors in both bioassays.

Isolates QQ Activity is Mediated Through AHLs Enzymatic Inactivation
To evaluate the catalyst nature of the QQ activity observed in the previous experiment, the extracellular compounds of all positive strains (FI314, FI330, FI333, FI335, FI346, FI383, FI423, FI436, FI442, and FI464) were mixed for 24 hours with 30 µ M of synthetic 3-Oxo-C6-HSL, before a bioassay with CV026 biosensor. In this, the reduction in the violacein halo when submitted to the H24 reaction mixture, when compared to a fresh reaction mixture (H0), indicates lactone degradation by the extracellular compounds present on the FI supernatants, and thus an enzymatic reaction. The FI extracellular compounds mixed with the 3-Oxo-C6-HSL led to a reduction in pigment production by the biosensor in all combinations, with strains FI314, FI330, FI346, and FI464 showing the highest activity ( Figure 2A). A reduction in the pigment production was also noticed when using the fresh (0H) reactions of strains FI314, FI330, and FI464, which might indicate the presence of signal blockers ( Figure 2A) on their supernatant.
To clarify if the degradation of the 3-Oxo-C6-HSL could be due to lactonase, FI extracellular compounds were simultaneously tested for lactonase enzymatic activity through acidification, since lactonase enzymatic reaction is pH-mediated and reversible by acidification. After the acidification process, the enzymatic reaction could be reversed, as confirmed by the regain of purple pigmentation intensity, suggesting a lactonase-type FI QQ activity ( Figure 2A). As expected, the negative control (LB medium mixed with 30 µ M of 3-Oxo-C6-HSL) did not reduce pigment production during the bioassay (Figure 2A).

Figure 2.
Activity and genomic detection of putative QQ lactonases. (A) Enzymatic degradation of 3-Oxo-C6-HSL by the fish isolates' extracellular compounds (FIs on the top), followed by reversion of the enzymatic reaction through acidification, revealed by the reduction and restoration of the violacein pigment production by the biosensor. All photos were taken with a Sony IMX240 camera and are at the same scale. (B) PCR detection of genes coding for a putative QQ lactonase (ytnP) and N-acyl homoserine lactonase (aiiA) in the genomes of B. subtilis 168 (Bsub) and fish isolates (FI numbers on top). The amplicon size, in base pairs (bp), is shown on the right. The figure was constructed using different zones of the agarose gel. PCR products marked with a red circle in the figure were sequenced using the corresponding forward and reverse primers (Table 1).
To elucidate the lactonases behind the observed QQ activities, all 10 FI isolates were first identified based on partial sequencing of the 16S rRNA gene (~1000 bp), as part of the Bacillus genera. FI314, FI330, FI346, and FI442 were identified as B. subtilis; FI333, and FI423 as B. amyloliquefaciens; FI335, FI383, and FI436 as B. velezensis; and FI464 as a B. , followed by reversion of the enzymatic reaction through acidification, revealed by the reduction and restoration of the violacein pigment production by the biosensor. All photos were taken with a Sony IMX240 camera and are at the same scale. (B) PCR detection of genes coding for a putative QQ lactonase (ytnP) and N-acyl homoserine lactonase (aiiA) in the genomes of B. subtilis 168 (Bsub) and fish isolates (FI numbers on top). The amplicon size, in base pairs (bp), is shown on the right. The figure was constructed using different zones of the agarose gel. PCR products marked with a red circle in the figure were sequenced using the corresponding forward and reverse primers ( Table 1).
To clarify if the degradation of the 3-Oxo-C6-HSL could be due to lactonase, FI extracellular compounds were simultaneously tested for lactonase enzymatic activity through acidification, since lactonase enzymatic reaction is pH-mediated and reversible by acidification. After the acidification process, the enzymatic reaction could be reversed, as confirmed by the regain of purple pigmentation intensity, suggesting a lactonase-type FI QQ activity ( Figure 2A). As expected, the negative control (LB medium mixed with 30 µM of 3-Oxo-C6-HSL) did not reduce pigment production during the bioassay (Figure 2A).
To elucidate the lactonases behind the observed QQ activities, all 10 FI isolates were first identified based on partial sequencing of the 16S rRNA gene (~1000 bp), as part of the Bacillus genera. FI314, FI330, FI346, and FI442 were identified as B. subtilis; FI333, and FI423 as B. amyloliquefaciens; FI335, FI383, and FI436 as B. velezensis; and FI464 as a B. pumilus ( Table 1). The presence of genes that were previously correlated with QQ activity in Bacillus species was first investigated using oligonucleotide primers described by Kalia, et al. [37] to amplify the Firmicutes AHL-lactonase gene aiiA (Table 1). Since no amplification could be obtained in the target FI (data not shown), novel oligonucleotide primers were specifically designed in highly conserved genomic regions to target the genes of interest: aiiA (N-acyl homoserine lactonase) and ytnP (probable quorum-quenching lactonase). As shown in Figure 2B, all strains except FI464 showed a PCR band with the expected size (559 bp) of ytnP gene. In isolate FI464, a strong PCR band was observed at a higher molecular weight (~1500 bp). However, only faint bands with the expected size (583 bp) of aiiA could be detected in FI314, FI330, FI333, FI383, FI423, and FI442.
Conjugating the previously observed genomic profile and QQ bioactivities, five PCR products were sequenced to confirm if they matched the targeted gene (bands marked in red in Figure 2B). All DNA sequences could be assigned to a protein family using BLASTx (https://blast.ncbi.nlm.nih.gov/Blast.cgi; accessed on 15 January 2020) ( Table 2). The amino acid sequences of putative AHL-lactonases were aligned with other known AHLlactonases, and the conserved motif "HXHXDH" present in the metallo-β-lactamase superfamily was searched for, as illustrated in Supplementary Figure S1A. Putative ytnP-like AHL-lactonases from FI314 and FI436 have the zinc-binding motif "HXHXDH" (Supplementary Figure S1A) and cluster with the B. subtilis 168 ytnP ( Supplementary Figure S1B), being identified through BlastX as ytnP-like metallo-hydrolase and MBL fold metallo-hydrolase, respectively. However, the high-molecular-weight band of FI464 did not correspond to a putative QQ lactonase but to a DAK2 domain-containing protein ( Table 2) and did not cluster to any QQ enzymes known in Bacillus spp. (Supplementary Figure S1B). Putative AHL-lactonase aiiA, from strains FI314 and FI383, clustered separately from the other AHL-lactonases in the metallo-β-lactamase family, and were identified as containing a rhodanese-like homology domain (Table 2). a Closest known protein using BLASTx based on partial sequences of QQ genes (~300-400 nt). b Query Coverthe percentage of the query sequence covered by the reference sequence. c Percent Identity-the percentage of similarity between the query sequence and the reference sequence.

Isolates QQ Compounds Can Interfere with Fish Pathogens AHLs
After establishing the putative lactonase type of FI QQ activity, FI QQ compounds were tested for interference with fish pathogens AHLs. For this, 13 different fish pathogens (Table 3) were studied for the production of AHLs' detectable by Chr. violaceum CV026 biosensor. From the 13 tested pathogens, only Aeromonas salmonicida, A. veronii, A. bivalvium, and Edwardsiella tarda could induce the production of a violacein pigment on the biosensor by cross-feeding (Supplementary Figure S2). As AHLs can diffuse through the cell, their production kinetics and cell-release were investigated on those four pathogens. By using pathogens' extracellular medium in a well-diffusion method, it was observed that the production of AHLs by A. veronii started at the beginning of its growth curve, lasting for 12 h, with a maximum peak at the transition from the late exponential to the early stationary phase of growth ( Figure 3A,B). In E. tarda, AHLs detection started at the transition from the exponential to stationary growth phase and was extended until 36 h of growth ( Figure 3A,B). Although observable by cross-feeding (Supplementary Figure S2), the use of an extracellular medium in the well-diffusion method did not allow for the detection of AHLs produced by A. salmonicida and A. bivalvium by the CV026 biosensor at 48 h of the assay ( Figure 3B).
Before ascertaining the FI QQ capacity against natural AHLs from fish pathogens, the QQ kinetics of FI314, FI436, and FI464 (selected by conjugating the previous QQ bioassays, molecular identification, and the QQ genomic profile) was assessed using synthetic 3-oxo-C6-HSL. For all strains, the maximum production of QQ compounds was during the early stationary growth phase (~8 h) (Supplementary Figure S3).
Fish pathogens AHLs were extracted from the cell-free supernatants of 6 h and 14 h cultures of A. veronii and E. tarda, respectively, and analyzed through agar well-diffusion assay using different supplementation amounts (10-100 µL in 8 mL of soft-agar) ( Figure 4). A. veronii crude AHL extracts induced a slight violacein pigmentation on CV026 biosensor with 100 µL of supplementation. The AHL crude extract from E. tarda induced purple pigmentation on the biosensor CV026 with 10-100 µL of supplementation. As illustrated in Figure 4, all three selected FI strains could inactivate the signals produced by A. veronii and E. tarda, with FI314 and FI464 showing a higher QQ potential. Additionally, a decrease in QQ activity could also be observed with an increase in E. tarda AHLs supplementation (Figure 4), indicating a concentration-dependent activity.
from the late exponential to the early stationary phase of growth ( Figure 3A,B). In E. tarda, AHLs detection started at the transition from the exponential to stationary growth phase and was extended until 36 h of growth ( Figure 3A,B). Although observable by cross-feeding (Supplementary Figure S2), the use of an extracellular medium in the well-diffusion method did not allow for the detection of AHLs produced by A. salmonicida and A. bivalvium by the CV026 biosensor at 48h of the assay ( Figure 3B). Before ascertaining the FI QQ capacity against natural AHLs from fish pathogens, the QQ kinetics of FI314, FI436, and FI464 (selected by conjugating the previous QQ bioassays, molecular identification, and the QQ genomic profile) was assessed using synthetic 3-oxo-C6-HSL. For all strains, the maximum production of QQ compounds was during the early stationary growth phase (~8h) (Supplementary Figure S3).
Fish pathogens AHLs were extracted from the cell-free supernatants of 6 h and 14 h cultures of A. veronii and E. tarda, respectively, and analyzed through agar well-diffusion assay using different supplementation amounts (10-100 µ L in 8 mL of soft-agar) ( Figure  4). A. veronii crude AHL extracts induced a slight violacein pigmentation on CV026 biosensor with 100 L of supplementation. The AHL crude extract from E. tarda induced purple pigmentation on the biosensor CV026 with 10-100 L of supplementation. As illustrated in Figure 4, all three selected FI strains could inactivate the signals produced by A. veronii and E. tarda, with FI314 and FI464 showing a higher QQ potential. Additionally, a  Biosensor's violacein pigment production when supplemented with natural AHLs extracted from A. veronii and E. tarda (10,20,40,60, 80 and 100 L) around wells containing cell-free supernatant of sporeforming fish isolates (FI numbers on top). All photos were taken with a Sony IMX240 camera and are at the same scale.

Isolates QQ Compounds Protect Zebrafish Larvae Upon E. tarda Challenge
The next question was whether the in vitro FI QQ activity against E. tarda AHLs could originate from an in vivo protection of FI strains to zebrafish larvae challenged with E.

Isolates QQ Compounds Protect Zebrafish Larvae upon E. tarda Challenge
The next question was whether the in vitro FI QQ activity against E. tarda AHLs could originate from an in vivo protection of FI strains to zebrafish larvae challenged with E. tarda.
For this, the maximum non-toxic extract concentration (MNTC) of each FI to be employed in protective assays was first established using 4 dpf zebrafish larvae (Supplementary Figure S4A). The results showed that extracts from all strains induced toxicity in zebrafish larvae when administrated at concentrations above 250 µg mL −1 and, thus, FI extracts were used at 250 µg mL −1 (MNTC). This concentration did not influence E. tarda growth (data not shown).
Secondly, an E. tarda infection model was established by exposing 10 dpf zebrafish larvae by immersion with 5 × 10 7 , 1 × 10 8, and 3 × 10 8 CFU mL −1 of E. tarda for 24 h. Larvae exposed to 3 × 10 8 CFU E.tarda mL −1 started to show mortality at 10 h post-infection (hpi) and rapidly progressed until 18 hpi, with 100% mortality (data not shown and Supplementary Figure S4). Mortalities in larvae exposed to 1 × 10 8 CFU E. tarda mL −1 began at 17 hpi and progressed through time, reaching~60% at 24 hpi. On the other hand, 5 × 10 7 CFU E. tarda mL −1 started to induce mortalities only at 23 hpi (Supplementary Figure S4B). Control larvae did not exhibit any mortality throughout the experimental trial. From the overall results, 1 × 10 8 CFU E. tarda mL −1 was selected as the bacterial concentration for the challenge experiment.
Finally, the protective effect of FI extracellular compounds was evaluated using the E. tarda infection model. As illustrated in Figure 5, FI extracellular compounds from FI314, FI436, and FI464 were able to protect zebrafish larvae from E. tarda infection, significantly increasing larvae survival rate when compared to the control (non-treated zebrafish larvae infected with E. tarda). In the control group, at 24 hpi, only 30% of zebrafish larvae survived, which resulted in 100% mortality at 48 hpi. By comparing treatments with the control group, after 48 hpi, FI314 increased the average survival rate of challenged larvae by 43% (p < 0.01), and strains FI436 and FI464 increased the survival rate upon challenge by 50% (p < 0.001).

Mar. Drugs 2021, 19, x FOR PEER REVIEW
Finally, the protective effect of FI extracellular compounds was evaluated us E. tarda infection model. As illustrated in Figure 5, FI extracellular compounds from FI436, and FI464 were able to protect zebrafish larvae from E. tarda infection, signif increasing larvae survival rate when compared to the control (non-treated zebraf vae infected with E. tarda). In the control group, at 24 hpi, only 30% of zebrafish survived, which resulted in 100% mortality at 48 hpi. By comparing treatments w control group, after 48 hpi, FI314 increased the average survival rate of challenged by 43% (p < 0.01), and strains FI436 and FI464 increased the survival rate upon cha by 50% (p < 0.001).

Discussion
Bacillus spp. have been extensively studied for their use in aquaculture due t probiotic attributes, which include the production of bioactive compounds and th ulation of the host immune response [40]. In addition to their well-known antimi activity, Bacillus spp. are also producers of quorum-quenching (QQ) molecules [27 The disruption of pathogens' communication or quorum-sensing via QQ molecu Figure 5. FI extracts protection of zebrafish larvae against infection with E. tarda. 7 dpf zebrafish larvae were immersed for 2 h with 250 µg mL −1 of each FI extract and three days later, challenged with E. tarda at a final concentration of 1 × 10 8 CFUs mL −1 for 24 h. Untreated larvae challenged with E. tarda and, untreated and unchallenged larvae were used as positive and negative control, respectively. Data are composed of three independent experiments. Significant differences (p < 0.01; p < 0.001) in relation to control are represented by asterisks (**, ***, respectively).

Discussion
Bacillus spp. have been extensively studied for their use in aquaculture due to their probiotic attributes, which include the production of bioactive compounds and the modulation of the host immune response [40]. In addition to their well-known antimicrobial activity, Bacillus spp. are also producers of quorum-quenching (QQ) molecules [27,29,41]. The disruption of pathogens' communication or quorum-sensing via QQ molecules has been proposed as a promising alternative to fighting bacterial infections in aquaculture [15], which remains a major constraint to the sustainable development of the sector. We recently described the potential of fish-gut Bacillus spp. isolates (FI) as a source of QQ molecules [27]. In this study, we took advantage of 200 FI isolated from the gut of different fish species (Sparus aurata, Dicentrarchus labrax, and Diplodus sargus) [24,27] to further explore their QQ potential, by testing their ability to partially or completely degrade AHLs' QS molecules used by gram-negative fish pathogens. Consistent with the literature, the results indicate that fish gut Bacillus spp. have QQ potential and, by testing their extracellular compounds, the majority of these Bacillus spp. produce and release QQ compounds to the extracellular environment. This observation contradicts previous reports that described AHL-degrading activities in Bacillus spp. as cytoplasmatic or cell-wall-associated [14,16,42] and might represent a technological advantage for QQ disease control, since compounds that work extracellularly are believed to exert less selective pressure in evolving resistance among pathogens [3,14,43].
AHLs can be degraded through the enzymatic activity of lactonases, acylases, or oxi-reductases. To date, mainly lactonases, but also one oxidoreductase and one putative acylase, have been described in Bacillus species [42,[44][45][46]. When an AHL-lactonase is present, cleavage of the homoserine lactone ring of the AHL molecule occurs. The opening of the lactone ring makes the AHL molecule incapable of binding to the target transcriptional regulators (e.g VanT, AhyR, and LuxR homologs), attenuating its effectiveness and detection by the biosensor [47]. This hydrolysis is pH-mediated and can be reversed by acidification. Taking this into consideration, the extracellular enzymatic activity of the positive FI isolates was tested, and all 10 strains enzymatically degraded the AHLs after 24 h of incubation, with a partial restoration of the AHL molecule, inferred by the recovery of the violacein pigment on the biosensor during the acidification process. The restoration of the violacein pigment on the biosensor after the acidification process indicated the putative presence of an AHL-lactonase. However, pigment regain was only partial, which may be explained by the lack of pH control during incubation, which is essential to the hydrolysis reversion of the lactone ring [48]. Although the presence of an acylase, an oxidoreductase, or small molecules that blocked the biosensor signal receptors cannot be ruled out, AHLs degradation seen by the smaller colour formation on the biosensor submitted to the 24 h AHL-SUP mixture when compared to the colour observed on the biosensor submitted to fresh (H0) AHL-SUP mixture, followed by colour restoration upon acidification, indicate that the observable QQ activity is probably due to a lactonase-like enzyme.
In the lactonase-like enzyme family, the aiiA gene and AiiA enzyme were the first to be discovered and characterized for their QQ activity in Bacillus spp. [16]. Over the years, different QQ studies highlighted the potential of the AiiA enzyme in the prevention of plant and animal bacterial infections [16,28,49]. In the present study, attempts to amplify the aiiA gene, both using the literature-described primers and primers designed by us, were unsuccessful. Despite the presence of light PCR bands in the agarose gel (using the primers designed in this study), the analysis of their nucleotide and translated sequences did not correspond to the aiiA gene or contain the AHL-lactonases' conserved zinc-binding motif "HxHxDH" [42]. Although Metallo-β-lactamase family members possess the same folding and conserved sequences, the group englobes proteins with divergent sequences and biological functions [50]. Thus, it was hypothesized that, by using the primers designed in homologous sequences, other Metallo-β-lactamase proteins were amplified, with no similarity to the aiiA gene. In fact, by considering the taxonomic identification of the QQ strains, only a few studies have reported the presence of the aiiA gene in B. subtilis and B. amyloliquefaciens [49,51], and none in B. vezelensis and B. pumilus.
Meanwhile, Schneider, Yepes, Garcia-Betancur, Westedt, Mielich and López [20] reported the expression of another QQ gene, the ytnP from B. subtilis, capable of interfering with the signaling pathways of biofilm formation and streptomycin production in Pseudomonas aeruginosa and Streptomyces griseus. Here, the ytnP gene was successfully amplified in 9 out of the 10 QQ strains. Protein sequence analysis of FI314 and FI436 showed similarity with ytnP-like and MBL fold proteins, respectively, and revealed the presence of the AHL-lactonase zinc-binding motif containing the key histidine residues "HxHxDH" of the lactonase architecture [42]. The YtnP enzyme has been described to accumulate in the cytoplasm, and only upon the presence of other antimicrobials and stress factors [20]. In the strains used in this study, the observed QQ activity was extracellular, and is thus unlikely to only be due to the action of YtnP. An additional undescribed QQ lactonase, or at least a differently regulated ytnP, must be present. The deletion of ytnP in the FI isolates background could provide a glimpse into their QQ mechanism, but transformation of these strains (both by chemical methods and by electroporation) has been unsuccessful to date (data not shown).
Additionally, despite showing a putative AHL-lactonase activity in the biochemical test, none of the test QQ genes nor the conserved motif of AHL-lactonase were amplified from FI464, identified as B. pumilus. In fact, to the authors' knowledge, there is only one report describing B. pumilus QQ potential. Nithya, Aravindraja and Pandian [46] reported a B. pumilus strain with a putative acylase activity, which effectively reduced biofilm formation and other virulence factors in P. aeruginosa. However, the authors did not characterize the protein in detail or provide the gene sequence. Thus, the FI464 genome is undergoing further investigation, as it is assumed that this strain possesses a completely different lactonase activity to the one described in the literature for the other Bacillus species.
The ability of the FI to interfere with fish pathogens QS was the core of this study. Thus, the three strains with the best QQ profile, FI314, FI436, and FI464, were evaluated for their ability to degrade the natural signals produced by different species of problematic fish pathogens. QS systems based on AHLs are well-described and reviewed in fish bacterial pathogens [8,12,13,[52][53][54][55][56][57][58]. Here, AHLs' production was evaluated by cross-feeding fourteen different fish pathogens, including species from Aeromonas, Vibrio, Photobacterium, Edwardsiella, and Shigella genera, with the biosensor Chr. violaceum CV026. Of the tested pathogens, only A. salmonicida, A. veronii, A. bivalvium, and E. tarda had the capacity to induce violacein pigmentation on the biosensor Chr. violaceum CV026. This biosensor has the limitation of being stimulated by AHLs with acyl chains ranging from C4 to C8 and, when these are present alongside long-acyl-chain molecules (C8-C14), inhibition of violacein production occurs [36]. This might explain the lack of violacein induction on the biosensor by the tested Vibrio spp., which are known to produce several QS molecules, including AHLs with different lengths and derivates, such as C4-HSL, C6-HSL, 3-oxo-C10-HSL, 3-oxo-C14-HSL [9,56,57,59]. Bruhn, Dalsgaard, Nielsen, Buchholtz, Larsen and Gram [52] also reported a lack of violacein induction on the CV026 biosensor when testing V. anguillarum, V. vulnificus, and Photobacterium damselae subsp. damselae strains, but demonstrated AHLs production in Vibrio spp. using another biosensor.
E. tarda and Aeromonas spp. have previously been reported to induce the violacein pigment on the CV026 biosensor [12,54,55,60]. The exception in these results, as anticipated, was the A. hydrophila LMG 2844 strain, as it was unable to induce an AHL-mediating response that was detectable by different biosensors, including CV026 [60,61]. An unexpected result was the lack of violacein pigment when testing T. maritimum, since Romero, Avendano-Herrera, Magarinos, Camara and Otero [13] reported that this species produces C4-HSL. Although the CV026 biosensor detect Ced4-HSL molecules, no activity was reported in the Flavobacteriaceae family using this biosensor [52], and, to the authors' knowledge, there is no study reporting violacein induction on a CV026 biosensor by T. maritimum AHLs. Moreover, genome sequencing of the T. maritimum strain NCIMB 2154 T revealed the absence of homologous genes for AHLs synthesis [62].
Next, the pathogens that induced violacein pigmentation on the Chr. Violaceum biosensor, i.e., A. salmonicida, A. veronii, A. bivalvium, and E. tarda, were tested for the maximum peak in AHLs production and extracellular accumulation. Although A. salmonicida and A. bivalvium induced the violacein pigment on the cross-feeding bioassays, they failed to induce it when testing the extracellular accumulation for 48 h. This might be due to low AHLs concentration or stability outside the cell. A. veronii accumulated AHLs during the whole exponential phase with a maximum peak at the time of transition to the stationary phase, followed by a rapid decline, as described by Jangid, et al. [63]. However, AHLs accumulation in E. tarda was only detected when the cells were entering the stationary phase, and was stable throughout this phase, with the maximum peak detected at 16 h of growth. Accordingly, Han, Li, Qi, Zhang and Bossier [55] also detected AHLs production during the E. tarda growth phase (1-21 h) using the Ag. tumefaciens KYC55 biosensor and, since this biosensor is considered to be ultra-sensitive in AHLs detection, the accumulation of AHLs was detected 5 h earlier.
A. veronii is known to produce natural short and medium acyl-chains, such as C6-HSL, C8-HSL, 3-oxo-C8-HSL, and 3-hydro-C8-HSL [64]. In CV026, C8 acyl chains led to an inhibition of violacein induction by other molecules, such as C6-HSL [36]. This might explain the minor induction of violacein pigment on the biosensor, observed when the crude and concentrated A. veronii extracts were used. Nonetheless, FI314 and FI464 were able to interfere with these natural AHLs, either through enzymatical degradation or by interrupting their detection by bacterial receptors. When testing different quantities of E. tarda AHLs supplementation, it could be observed that an increase in supplementation led to a decrease in QQ activity, which might indicate an enzymatic degradation of C4-HSL, C6-HSL, 3-oxo-C6-HSL, and C7-HSL [54,55] by all the tested FIs. Recent studies have highlighted the QQ potential of Bacillus spp. against natural AHLs produced by fish pathogens such as A. hydrophila [30,65,66], Yersinia ruckeri [34], and V. harveyi and V. alginolyticus [41]. Similarly, Gui, Wu, Liu, Wang, Zhang and Li [53] demonstrated that a purified lactonase aiiA AI96 from Bacillus sp. enzymatically inactivated the AHLs produced by A. veronii, as well as other QS-controlled behaviors. To the authors' knowledge, to date, only Romero, et al. [67] have described an in vitro quenching of E. tarda AHLs (C6-HSL and 3-oxo-C6-HSL) using Tenacibaculum sp. strain 20J cell extracts. Thus, this is the first report demonstrating the potential of QQ Bacillus spp. in inhibiting the natural AHLs produced by E. tarda. E. tarda is an important bacterial pathogen that causes hemorrhagic septicemia, edwardsielosis, affecting economically important aquaculture fish species such as turbot [68], Senegalese sole [69], and tilapia [70][71][72], and has been associated with gastro-and extraintestinal infections in humans [73,74].
Bacillus QQ strains have been used in several in vivo studies for fish disease mitigation, but, to date, none has addressed E. tarda infections. For example, oral administration of purified QQ enzyme AiiA increased zebrafish survival by 40% when challenged with A. hydrophila [28], and increased shrimp survival by 50% when challenged with V. parahaemolyticus [33]. Similarly, when cells of QQ B. cereus and B. thuringiensis strains were fed to rainbow trout, fish survival upon infection with Y. ruckeri increased by 80% [34]. Additionally, Chen, et al. [75] co-injected a purified QQ enzyme (AiiA B546) with A. hydrophila, reducing common carp mortality by 25%, and, in a similar experiment, cells of the QQ B. licheniformis T-1 strains decreased zebrafish mortality by 50% when co-injected with A. hydrophila [29].
In the present study, the treatment of zebrafish larvae with FI314, FI436, and FI464 extracts significantly reduced their mortality when challenged with E. tarda by immersion. In E. tarda, the routes of infection are believed to be the gut, the skin, and the gills [76]. The gills and the skin are in constant contact with the environment and, consequently, are accessible to pathogen entry. Thus, the presence of QQ molecules at these sites may help prevent or delay fish infection. On the other hand, in the present study, there was no physical contact between the FIs extracts and E. tarda, suggesting that these molecules can circulate through the host, exerting their protective effect. Although FIs extracts did not inhibit E. tarda growth (data not shown), a possible direct stimulus in the larvae immune system, facilitating disease resistance, cannot be ruled out. This interpretation is only speculative and requires further investigation, including the determination of a putative stimulus in the fish immune system using such extracts. Importantly, the extracts showed good stability (up to 12 months) under no specific storage conditions (room temperature). Moreover, a small bacterial culture volume (200 mL) allowed lyophilized extract to be obtained, make up to 40 L of treating water. These characteristics reinforce the practical application of these extracts in the aquaculture industry.
As a conclusion, this work describes three Bacillus spp. which are capable of extracellular quenching E. tarda AHLs while protecting the model zebrafish larvae from infection. The lack of studies regarding E. tarda infection and its crescent impact in aquaculture emphasizes the novelty and importance of this study. Nonetheless, further studies are required to fully characterize the QQ molecules responsible for the bioactivities described and to clarify the QQ mechanism involved. QS plays an important role in bacterial pathogenesis and virulence; thus, the QQ molecules from FI314 (B. subtilis), FI436 (B. vezelensis), and FI464 (B. pumilus) may be promising tools for disease control in aquaculture.

Evaluation of Isolates QQ Activity
A flow diagram with the methodology used for evaluating QQ activity is presented in Supplementary Figure S5.
The extracellular QQ activity was measured in all positive strains from the previous assay. For that, cell-free supernatant of each FI was prepared from overnight cultures grown at 37 • C and 140 rpm, followed by centrifugation for 10 min at 13,000× g and sterilization by filtration with 0.22 µm cellulose acetate filter. LB agar plates were overlaid with LB soft agar (0.8% agar) inoculated with Chr. violaceum WT (OD 600~0 .1), or with Chr. violaceum CV026 (OD 600~0 .1) supplemented with 5 µM of 3-Oxo-C6-HSL. Once the plates solidified, 9 mm diameter wells were punched and filled with 100 µL of the cell-free supernatant of each FI. As the cell-free supernatants of all fish isolates tested do not interfere with the biosensor's growth, the zones of violacein pigmentation inhibition around the wells after 48 h at 30 • C were considered a positive result for QQ extracellular activity. The laboratory strain B. subtilis 168 was used as a control for FIs bacterial growth and strains FI314, FI330, and FI442 were used as a positive control for QQ activity, as described earlier [27]. All digital photos were taken with a Sony IMX240 camera and zones (in mm) of pigment inhibition recorded.

AHLs Enzymatic Inactivation by Isolates' Extracellular Compounds
Fish isolates' cell-free supernatant was tested for AHL enzymatic degradation of 30 µM of 3-Oxo-C6-HSL, using a well-diffusion method, as follows: LB plates were overlaid with 8 mL of LB soft agar (0.8% agar) previously inoculated with Chr. violaceum CV026 (OD600~0.1). After plate solidification, 9 mm diameter wells were punched and filled with 100 µL of AHL-SUP reaction mixtures, (cell-free supernatant of each FI strain mixed with 30 µM of 3-Oxo-C6-HSL. To evaluate enzymatic activity, the AHL-SUP reaction mixtures were incubated at room temperature, with agitation at 120 rpm, for 0 h and 24 h, before using in the bioassays with Chr. violaceum CV026. LB media with and without the same concentration of 3-Oxo-C6-HSL were used as negative controls. An intensity and size reduction in the violacein pigment halo on the biosensor submitted to both reaction mixtures 0 h and 24 h was considered a positive result for enzymatic degradation. The method described by Edwin A. Yates [48] was used to elucidate whether the enzymatic degradation of the 3-Oxo-C6-HSL could be due to a lactonase. Reaction mixtures were acidified with 10 N HCL to pH 2.0, and then used again in a new bioassay with Chr. violaceum CV026, as described. Since lactonase enzymatic reaction is pH-mediated and reversible by acidification, the restoration of the violacein pigment halo on Chr. violaceum CV026 is considered positive for lactonase activity. All digital photos were taken with a Sony IMX240 camera and zones (in mm) of pigment inhibition were recorded.

Design of QQ Primers
To obtain a set of primers specific to genes encoding putative QQ enzymes, an initial search was conducted at the Protein Knowledgebase -UniProtKB for "Bacillus Quorum Quenching lactonase". Selected enzymes included YtnP (probable QQ lactonase) (https:// www.uniprot.org/uniprot/O34760, accessed on 9 June 2019) and AiiA (N-acyl homoserine lactonase) (https://www.uniprot.org/uniprot/Q9L8R8, accessed on 9 June 2019). The protein sequence of each enzyme was used to search for similar proteins in the translated nucleotide database using NCBI (https://www.ncbi.nlm.nih.gov, accessed on 9 June 2019). Nucleotide sequence alignments with ClustalW (GenomeNet, Kyoto University, Japan) allowed for the detection of regions of sequence conservation, used to design a pair of primers for each enzyme-encoding gene (ytnP and aiiA) with the SnapGene software version 5.2.3 (GSL Biotech LLC, San Diego, CA, USA) ( Table 1).
Phylogenetic analysis was performed with the GenBank non-redundant nucleotide database (Blastn) and the GenBank protein database using a translated nucleotide sequence (Blastx) with BLAST (http://www.ncbi.nlm.nih.gov, accessed on 15 January 2020). The amino acid sequences of the putative AHL-lactonase enzymes were aligned with ClustalW software (https://www.genome.jp/tools-bin/clustalw, accessed on 15 January 2020) and the phylogenetic tree was built using the neighbor-joining method available in ClustalW software.
Pathogens' AHLs-production kinetics were evaluated in the supernatant of A. salmonicida, A. veronii, A. bivalvium and E. tarda. In brief, an inoculum (OD 600~0 .05) of A. bivalvium, A. salmonicida, A. veronii and E. tarda was prepared in BHI medium and grown for 48 h at 25 • C (or 37 • C in the case of E. tarda), 140 rpm. Every 2 hours (or every 4 hours after the first 24 h of growth), the optical density (OD 600 ) was measured and the pathogens' supernatant was obtained by centrifugation for 10 min at 16,000× g, and filtration with 0.22 µm cellulose acetate filter. The revelation of AHLs in the pathogen's supernatant was performed by overlaying a LB agar plate with 8 mL of LB soft agar (0.8% agar) inoculated with Chr. violaceum CV026 (OD 600~0 .1). After plate solidification, 9 mm diameter wells were punched and filled with 100 µL of each pathogen's supernatant. Plates were incubated for 48 h at 30 • C and violacein pigment halos around the wells were considered a positive result. All digital photos were taken with a Sony IMX240 camera (Sony, Tokyo, Japan)and zones (in mm) of recorded pigment inhibition.

Extraction of Fish Pathogens' AHLs
The AHLs produced by A. salmonicida, A. veronii, A. bivalvium, and E. tarda were extracted as described in [78], with some modifications. In brief, an inoculum of each bacterial strain (OD 600~0 .05) was prepared in 25 mL of BHI medium from overnight cultures. A. salmonicida, A. veronii, A. bivalvium were grown for 6 h at 25 • C, and E. tarda was grown for 14 h at 37 • C, 140 rpm. Pathogens' supernatant was obtained from centrifugation for 10 min at 16,000× g, and filtration with 0.22 µm cellulose acetate filter and mixed with an equal volume of acidified ethyl acetate (0.1% of acetic acid). Mixtures were shaken for 30 min, followed by phase separation. The organic phases were pooled and stored at 4 • C. The extraction procedure was repeated three times to improve AHLs extraction. The pooled fraction was concentrated in a rotary evaporator at room temperature. Finally, the dried extract was dissolved in 500 µL of ethyl acetate and stored at 4 • C until use.

Fish Isolates QQ Activity on Fish Pathogens' AHLs
Fish isolates' QQ activity on A. salmonicida, A. veronii, A. bivalvium, and E. tarda AHL's was evaluated by overlaying LB plates with 8 mL of LB soft agar inoculated with Chr. violaceum CV026 (OD 600~0 .05) supplemented the natural AHLs extracted from the fish pathogens (10, 20, 40, 60, 80 and 100 µL). Once the plates solidified, 9 mm diameter wells were punched and filled with 100 µL of cell-free supernatant of each fish isolate strain. As in previous bioassays, zones of violacein inhibition around the wells (without interference on biosensor growth) after 48 h at 30 • C were considered a positive result for QQ activity. All digital photos were taken with a Sony IMX240 camera and zones (in mm) of pigment inhibition were recorded.

Ethics Statement
Zebrafish experiments and handling were approved by the Animal Welfare Committee of the Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), performed by trained scientists (with FELASA category C), carried out in a registered installation (N16091.UDER), in compliance with the European directive 2010/63/EU for the care and use of laboratory animals.

Zebrafish Larvae General Care
Zebrafish embryos were obtained from a wild-type zebrafish broodstock, and incubated in egg water at 28 • C under a photoperiod of 14 h of light:10 h of darkness until hatching. After hatching, larvae were kept in the same conditions and from 6 dpf were fed twice a day (diet containing 36.7% of total crude protein and 15% of total lipids). After each experiment, the surviving larvae were euthanized with a lethal dose of tricaine methanesulfonate (MS-222, 300 mg L −1 ).

Isolates Extracts Preparation and Testing for Toxicity in Zebrafish Larvae
The extracts of the 3 most promising QQ fish isolates were obtained by freeze-drying the filtered cell-free supernatant of 8 h cultures and resuspending it in sterile 1×PBS.
The evaluation of their in vivo toxicity was performed using zebrafish larvae (Danio rerio) as a model, following the Organisation for Economic Co-operation and Development (OECD) Guidelines for Fish Embryo Toxicity Tests [79].
Zebrafish larvae at 4 days post-fertilization (dpf) were distributed into 6-well plates containing 10 larvae/well in 5 mL of egg water (26.4 mg L −1 of Instant Ocean®Salt) and exposed to fish isolates' extracts with concentrations ranging from 67.5 µg mL −1 to 1 mg mL −1 . Larval mortality was recorded at 4, 5, 6, and 7 dpf, and the dead larvae were removed and discarded. Larvae kept in egg water (without treatment) were used as a negative control. The experiment was performed in triplicate to determine the maximum non-toxic extract concentration (MNTC) to be used in subsequent assays.

E. tarda Infection Model
Zebrafish larvae were used to establish an infection model of E. tarda by bath immersion. E. tarda was cultured for 24 h in BHI at 37 • C with 140 rpm, pelleted by centrifugation (6000× g ) at room temperature, washed twice with sterile 1×PBS and then diluted to the correct concentration in 1×PBS. Before the establishment of the infection model, bacterial cell densities ranging from 10 4 to 10 9 were tested to evaluate their virulence in zebrafish larvae during 24 h and determine the lowest lethal concentration causing 100% mortalities (5 × 10 8 CFUs mL −1 ) and the non-lethal dose (1 × 10 7 CFUs mL −1 ) (data not shown).
Zebrafish larvae at 10 dpf were distributed into 6-well plates containing 10 larvae/well in 5 mL of Egg water and inoculated with 5 × 10 7 , 1 × 10 8 , and 3 × 10 8 CFUs mL −1 of E. tarda. After inoculation, larvae were fed, and the plate was incubated at 28 • C. The E. tarda inoculum was kept in the water throughout the whole experiment (24 h). Cumulative mortalities were registered for 24 h and dead larvae found during the assay were removed and discarded. Control groups were included: (i) non-inoculated larvae, with egg-water only; (ii) larvae inoculated with 1×PBS. The experiment was independently performed 3 times.

Fish Isolates' Protection Assay against E. tarda Infection in Zebrafish Larvae
The fish isolates' protection of zebrafish larvae against E. tarda infection was performed by testing the lyophilized extracts at a final concentration of 250 µg mL −1 . Before the assay, a pre-treatment experiment was performed, where zebrafish larvae were treated with the extracts once, twice, or thrice for 2 or 24 h before challenge with E. tarda, allowing for the establishment of the best protection method. Thus, at 4 dpf, 10 healthy larvae were distributed into each well of a 6-well plate, containing 5 mL of Egg water. Larvae were treated with the extracts once after mouth's opening (7 dpf), for 2 h at 28 • C and then transferred to new 5 mL egg water. The treated 10 dpf larvae were challenged by immersion with E. tarda at 1 × 10 8 CFU mL −1 . After inoculation, larvae were fed, and the plate was incubated at 28 • C for 24 h. Cumulative mortalities were registered between 16 and 24 h and the dead larvae were removed and discarded. Control groups were included: (i) non-treated larvae inoculated with E. tarda; (ii) non-inoculated larvae; (iii) larvae inoculated with 1×PBS. The experiment was independently performed 3 times.

Statistical Analysis
Survival data were analysed using Kaplan-Meier, and group differences were analysed by the log-rank, using the GraphPad Prism 9 software.
The one-way ANOVA was performed to compare between treatments and the control, using the SPSS 26.0 software (IBM Corp., New York, NY, USA) package for Windows. When p-values were significant (p < 0.05), means were compared with Dunnett's test.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10 .3390/md19110602/s1, Table S1: Identification of the 10 fish-gut isolates with QQ activity, using 16S rRNA gene analysis. Figure S1: Amino acid sequence comparison of the putative AHL-lactonases with known AHL-lactonase enzymes. Figure S2: Detection of AHLs production by gram-negative fish pathogens using Chr. violaceum CV026 as a biosensor. Figure S3: Growth curves and QQ kinetics of FI314, FI436 and FI464. Figure S4: Toxicity of fish isolates' extracellular compounds and establishment of E. tarda infection model in zebrafish larvae. Figure S5: Flow diagram of the methodology used for evaluating FI isolates QQ activity.  (Foundation for Science and Technology), under the POCH program; CRS has a scientific employment contract supported by national funds through FCT-Portuguese Foundation for Science and Technology. This research was partially supported by the Strategic Funding UIDB/04423/2020 and UIDP/04423/2020, UIDB/04033/2020 and UIDB/00772/2020 through national funds provided by FCT and European Regional Development Fund (ERDF), in the framework of the programme PT2020.
Institutional Review Board Statement: Animal experiments were approved by the Animal Welfare Committee of the Interdisciplinary Centre of Marine and Environmental Research (CIIMAR) and carried out in a registered installation (N16091.UDER) and were performed by trained scientists (following FELASA category C recommendations) in full compliance with national rules and following the European Directive 2010/63/EU of the European Parliament and the European Union Council on the protection of animals used for scientific purposes.
Data Availability Statement: 16S rRNA gene sequences of fish isolates described in this manuscript have been deposited in GenBank with the accession numbers provided in Table 2. Authors confirm that all relevant data are included in the article.

Conflicts of Interest:
RJ is an employee of Epicore Inc., a subsidiary of Archer Daniels Midland, which supported this research by completing a commercial licensing agreement for the potential utilization of the probiotic bacteria FI314, FI330, FI442 used in this research, in commercial products for aquaculture. The opinions expressed in the manuscript are those of the authors and do not necessarily reflect company policies. All other authors declare no competing interest.